Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Erik Thunnissen, Rafael Rosell
-
+
Session Moderator
10:45 - 10:45 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:45 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
MA02.01 - Session Introduction
10:45 - 10:46 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
MA02.02 - Session Introduction
10:46 - 10:47 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
MA02.03 - The Evolution of Lung Neuroendocrine Tumors
10:47 - 10:52 | Presenter: Nicolas Alcala
- Abstract
Loading... -
+
MA02.04 - Molecular Drivers and Therapeutic Targets for Neuroendocrine Transformation in Lung Cancer
10:52 - 10:57 | Presenter: Triparna Sen
- Abstract
Loading... -
+
MA02.05 - Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations
10:57 - 11:02 | Presenter: Jie Huang
- Abstract
Loading... -
+
MA02.06 - Discussant
11:02 - 11:12 | Presenter: Yuko Minami
- Abstract
Loading... -
+
MA02.07 - Aurora A Kinase Inhibition with VIC-1911Potentiates KRASG12C Inhibitor and Overcomes Resistance to Sotorasib in Lung Cancer
11:12 - 11:17 | Presenter: Jong Woo Lee
- Abstract
Loading... -
+
MA02.08 - Trametinib Inhibition of MEK1 2 Upregulates PD-L1 Expression in KRAS-Mutant NSCLC Through ID1 Downregulation
11:17 - 11:22 | Presenter: Ander Puyalto
- Abstract
Loading... -
+
MA02.09 - Impact of Baseline Clinicopathologic and Genomic Features on Outcomes to KRAS G12C Inhibitors in Patients with NSCLC
11:22 - 11:27 | Presenter: Giuseppe Lamberti
- Abstract
Loading... -
+
MA02.10 - Discussant
11:27 - 11:37 | Presenter: Sally Lau
- Abstract
Loading... -
+
MA02.11 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
EP05.01-001 - Hispanic Patients with Unresectable Stage III NSCLC under PACIFIC Protocol: Evidence of Interior Outcomes and Health Inequity
Presenter: Andres F Cardona- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-011 - Design of a Phase I Trial (TOTEM) to Test Repotrectinib in Combination with Osimertinib in Advanced, Metastatic EGFR-Mutant NSCLC
Presenter: Andrés Aguilar- Abstract
Loading... -
+
EP08.02-032 - High Efficiency Multiplex Detection of Molecular Alterations in Supernatants of Pleural Effusion and Cerebrospinal Fluid
Presenter: Clara Mayo de las Casas- Abstract
Loading... -
+
EP08.02-120 - MET Alterations at Presentation in NSCLC Patients Harboring EGFR Mutations and ALK, RET and ROS1 fusions
Presenter: Núria Jordana- Abstract
Loading... -
+
EP08.02-135 - Anti-EGF Antibodies Significantly Improve the Activity of MET and KRAS Inhibitors in Preclinical Models of Non-small Cell Lung Cancer (NSCLC)
Presenter: Silvia Garcia-Roman- Abstract
Loading... -
+
EP08.02-159 - Post Hoc Analyses of Dacomitinib-Associated Skin Disorders and Efficacy in the ARCHER 1050 Study
Presenter: Lin Wu- Abstract
Loading...
-
+
EP16.02 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
-
+
EP16.02-007 - Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
Presenter: Estela Sánchez-Herrero- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-002 - Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)
Presenter: Andres F Cardona- Abstract
Loading... -
+
EP16.03-003 - Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC)
Presenter: Andres F Cardona- Abstract
Loading...
